The company is seeking approval from the US regulator for Vraylar (cariprazine) as an add-on to conventional ... not respond to typical antidepressant medications. The dopamine D2/D3 receptor ...
Many medications that are commonly referred to as “weight loss drugs” are not actually FDA-approved for this purpose. One of the most popular—Ozempic—is a type 2 diabetes drug that’s often prescribed ...